Malignant Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. [Phase 2]
Phase 2 trial update of sorafenib tosylate in malignant mesothelioma has completed (status: COMPLETED).
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: SU5416 in Treating Patients With Malignant Mesothelioma [Phase 2]
The clinical trial update reports the completion of a Phase 2 study of SU5416 in patients with malignant mesothelioma, sponsored by the Nati…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung [Phase 2]
Phase 2 trial evaluating erlotinib in patients with malignant mesothelioma of the pleura; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Gefitinib in Treating Patients With Malignant Mesothelioma [Phase 2]
Gefitinib was studied in a Phase 2 trial for malignant mesothelioma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
This document reports the results of a Phase 2 trial of dasatinib in patients with previously treated malignant mesothelioma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [Phase 1]
Phase 1 clinical trial evaluating erlotinib in patients with solid tumors and liver or kidney dysfunction has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer [NA]
This trial evaluated EF5 as a hypoxia marker to detect oxygen levels and vasculature in tumor cells during photodynamic therapy for intraper…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma [Phase 2]
This entry reports that the Phase 2 trial of Vandetanib for inoperable or relapsed malignant mesothelioma has been terminated, with results …
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma [Phase 2]
Phase 2 study evaluating tremelimumab as monotherapy for malignant mesothelioma is being conducted; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed [Phase 2]
Phase 2 trial evaluating raltitrexed in patients with unresectable malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura [Phase 3]
Phase 3 trial comparing cisplatin with or without raltitrexed in malignant mesothelioma of the pleura has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma [Phase 2]
Open-label Phase II trial evaluating gefitinib (IRESSA) in patients with malignant mesothelioma has been completed. The study assessed the s…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs [Phase 1]
A Phase 1 clinical trial evaluating inhaled doxorubicin for advanced solid tumors affecting the lungs has completed, including patients with…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) plus erlotinib (Tarceva) in previously treated malignant mesothelioma. The trial has complete…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluated pemetrexed with cisplatin and vitamin B12 in patients with unresectable malignant mesothelioma of the chest. The s…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma [Phase 2]
A Phase 2 trial by Roswell Park Cancer Institute evaluating surgery combined with photodynamic therapy for malignant mesothelioma has comple…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma [Phase 2]
This clinical trial update reports a Phase 2 study evaluating cisplatin with either pemetrexed (Alimta) or gemcitabine in a long infusion fo…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment [Phase 1]
Phase 1 study evaluating the safety and tolerability of CRS-207, a live-attenuated Listeria monocytogenes-based cancer vaccine, in adults wi…
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma [Phase 2]
Phase 2 efficacy study of oral Milataxel (TL139) for malignant mesothelioma. The document provides trial information but does not report res…
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma [Phase 2]
Phase II clinical trial evaluating the combination of Glivec (imatinib) and Gemzar (gemcitabine) in unresectable, refractory malignant mesot…